Ardelyx (ARDX) Gains from Investment Securities (2013 - 2025)
Ardelyx (ARDX) reported Gains from Investment Securities of -$6000.0 for Q4 2025, up 99.19% on a YoY basis from -$3012.1 in Q4 2024, and up 99.82% quarter-over-quarter from -$3.4 million in Q3 2025.
Ardelyx (ARDX) Gains from Investment Securities (2013 - 2025) Analysis & Trends
Ardelyx has reported Gains from Investment Securities for 13 years, with the latest figure at -$6000.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Investment Securities rose 99.19% year-over-year to -$6000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.7 million (down 169.71% YoY), and the FY2025 full-year result was $485000.0, up 82.33% from the prior year.
- Gains from Investment Securities for Q4 2025 stood at -$6000.0, up from -$3.4 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $2.2 million in Q1 2025, with the low at -$3.4 million in Q3 2025.
- Historically, Gains from Investment Securities has averaged $99066.7 across 5 years, with a median of $19000.0 in 2023.
- Annual changes were most pronounced in 2021 — Gains from Investment Securities soared 67300.0% — and 2024, when it sank 2425.0%.
- Ardelyx's Gains from Investment Securities stood at $674000.0 in 2021, then sank by 99.26% to $5000.0 in 2022, then soared by 540.0% to $32000.0 in 2023, then slumped by 2425.0% to -$744000.0 in 2024, then jumped by 99.19% to -$6000.0 in 2025.
- The last three Gains from Investment Securities figures came in at -$6000.0 (Q4 2025), -$3.4 million (Q3 2025), and $1.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6,000.00 |
| Dec 31, 2025 | -6,000.00 |
| Sep 30, 2025 | -3.39 Mn |
| Sep 30, 2025 | -3.39 Mn |
| Jun 30, 2025 | 1.67 Mn |
| Jun 30, 2025 | 1.67 Mn |
| Mar 31, 2025 | 2.21 Mn |
| Mar 31, 2025 | 2.21 Mn |
| Dec 31, 2024 | -744,000.00 |
| Dec 31, 2024 | -744,000.00 |
| Sep 30, 2024 | 738,000.00 |
| Sep 30, 2024 | 738,000.00 |
| Jun 30, 2024 | 272,000.00 |
| Jun 30, 2024 | 272,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Jun 30, 2023 | 19,000.00 |
| Jun 30, 2023 | 19,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 5,000.00 |